Eligibility for GLP-1 medications is assessed individually based on medical history, BMI, and metabolic health indicators during your initial evaluation
Some reasons patients consider deprescription include: Negative side effects Cost and coverage challenges Difficulty adhering to treatment Reaching their health goals Hitting a weight-loss plateau Preference not to remain on medication long term Without a comprehensive lifestyle and nutrition plan, many patients who stop GLP-1s regain the weight they lost
Frequency: Administer up to two subcutaneous injections daily, such as two hours prior to and after the subject has undergone physical activity
Increased Fertility If a woman is living with obesity, this means there is likely also significant inflammation and potentially abnormal testosterone levels, says Szoke, adding that obesity can affect ovulation and menstrual cycles, as well
One hypothesized mechanism for these potential protective actions against liver cell fibrosis might involve the modulation of matrix metalloproteinase (MMP) activity and the suppression of tissue inhibitors of MMPs (TIMPs)